391 related articles for article (PubMed ID: 26851035)
1. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
[TBL] [Abstract][Full Text] [Related]
3. NEK2 Promotes Hepatoma Metastasis and Serves as Biomarker for High Recurrence Risk after Hepatic Resection.
Chang YY; Yen CJ; Chan SH; Chou YW; Lee YP; Bao CY; Huang CJ; Huang W
Ann Hepatol; 2018 Aug; 17(5):843-856. PubMed ID: 30145571
[TBL] [Abstract][Full Text] [Related]
4. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma.
Li G; Zhong Y; Shen Q; Zhou Y; Deng X; Li C; Chen J; Zhou Y; He M
Int J Oncol; 2017 Feb; 50(2):405-413. PubMed ID: 28101574
[TBL] [Abstract][Full Text] [Related]
5. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K
Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
11. The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus.
Shi J; He YY; Sun JX; Guo WX; Li N; Xue J; Cheng SQ
Ann Hepatol; 2015; 14(2):198-206. PubMed ID: 25671829
[TBL] [Abstract][Full Text] [Related]
12. High STAT4 expression is a better prognostic indicator in patients with hepatocellular carcinoma after hepatectomy.
Wubetu GY; Utsunomiya T; Ishikawa D; Yamada S; Ikemoto T; Morine Y; Iwahashi S; Saito Y; Arakawa Y; Imura S; Kanamoto M; Zhu C; Bando Y; Shimada M
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S721-8. PubMed ID: 24965572
[TBL] [Abstract][Full Text] [Related]
13. Low expression of NEK2 is associated with hepatocellular carcinoma progression and poor prognosis.
Fu L; Liu S; Wang H; Ma Y; Li L; He X; Mou X; Tong X; Hu Z; Ru G
Cancer Biomark; 2017 Jul; 20(1):101-106. PubMed ID: 28759960
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
15. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
[TBL] [Abstract][Full Text] [Related]
16. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
Yin F; Han X; Yao SK; Wang XL; Yang HC
World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
[TBL] [Abstract][Full Text] [Related]
17. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(4):1207-15. PubMed ID: 25632194
[TBL] [Abstract][Full Text] [Related]
18. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection.
Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ
J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]